Trial Profile
Insulin sensitivity in patients with schizophrenia or schizoaffective disorder treated with olanzapine and risperidone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 01 Aug 2011 Results published in the Diabetes, Obesity and Metabolism.
- 24 Sep 2008 Status changed from recruiting to completed.
- 29 Dec 2005 New trial record.